Regeneron Pharmaceuticals, Inc. (0R2M.L)
USD 732.14
(-1.06%)
USD 732.14
(-1.06%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.59 Billion | 5.01 Billion | 7.08 Billion | 2.61 Billion | 2.43 Billion | 2.19 Billion |
| Net Income | 3.95 Billion | 4.33 Billion | 8.07 Billion | 3.51 Billion | 2.11 Billion | 2.44 Billion |
| Depreciation & Amortization | 421 Million | 341.4 Million | 286.2 Million | 235.9 Million | 210.3 Million | 148.2 Million |
| Deferred income taxes | -837.8 Million | -746.4 Million | -147.1 Million | 75.6 Million | -130.6 Million | -140 Million |
| Stock-based compensation | 885 Million | 725 Million | 601.7 Million | 432 Million | 464.3 Million | 427.4 Million |
| Change in working capital | -94.1 Million | -243.3 Million | -1.91 Billion | -1.5 Billion | -200.5 Million | -697 Million |
| Other non-cash items | 266.3 Million | 599.8 Million | 181.7 Million | -135 Million | -29.3 Million | 12.1 Million |
| Investing Cash Flow | -3.18 Billion | -3.78 Billion | -5.38 Billion | -70.6 Million | -2.02 Billion | -1.46 Billion |
| Investments in PPE | -926.4 Million | -590.1 Million | -551.9 Million | -614.6 Million | -429.6 Million | -383.1 Million |
| Acquisitions | -54.9 Million | -230.3 Million | 551.9 Million | 614.6 Million | 429.6 Million | 1.06 Billion |
| Investment purchases | -11.64 Billion | -7.48 Billion | -7.04 Billion | -3.24 Billion | -3.2 Billion | -1.84 Billion |
| Sales/Maturities of investments | 9.44 Billion | 5.55 Billion | 2.21 Billion | 3.78 Billion | 1.6 Billion | 775.6 Million |
| Other Investing Activities | -2.41 Billion | -1.02 Billion | -551.9 Million | -614.6 Million | -429.6 Million | -1.07 Billion |
| Financing Cash Flow | -1.79 Billion | -1 Billion | -1 Billion | -1.97 Billion | -252.1 Million | -77.1 Million |
| Debt repayment | - | - | - | -1.5 Billion | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -2.93 Billion | -2.52 Billion | -2.67 Billion | -6.52 Billion | -463.9 Million | -191.6 Million |
| Common Stock Issuance | 1.14 Billion | 1.51 Billion | 1.67 Billion | 2.57 Billion | 211.8 Million | 114.5 Million |
| Other Financing Activities | -700.6 Million | -445.7 Million | -1.03 Billion | 3.48 Billion | -188 Million | -187.2 Million |
| Accounts receivables | -338.8 Million | 707.8 Million | -1.92 Billion | -1.35 Billion | -473.1 Million | -268.9 Million |
| Accounts payables | 598.6 Million | -138.4 Million | 866.1 Million | 118.9 Million | 444.5 Million | 210 Million |
| Inventory | -271.7 Million | -696.5 Million | -494.3 Million | -529.4 Million | -335.5 Million | -387.9 Million |
| Other working capital | -82.2 Million | -116.2 Million | -360.9 Million | 263 Million | 163.6 Million | -250.2 Million |
| Cash at beginning of period | 3.11 Billion | 2.89 Billion | 2.2 Billion | 1.63 Billion | 1.48 Billion | 825.2 Million |
| Cash at end of period | 2.73 Billion | 3.11 Billion | 2.89 Billion | 2.2 Billion | 1.63 Billion | 1.48 Billion |
| Capital Expenditure | -926.4 Million | -590.1 Million | -551.9 Million | -614.6 Million | -429.6 Million | -383.1 Million |
| Effect of forex changes on cash | -400 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -381.6 Million | 221.3 Million | 690.8 Million | 577 Million | 150.1 Million | 655 Million |
| Free Cash Flow | 3.66 Billion | 4.42 Billion | 6.52 Billion | 2 Billion | 2 Billion | 1.81 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.34 Billion | 1.43 Billion | 722 Million | 3.95 Billion | 1.15 Billion | 1 Billion |
| Depreciation & Amortization | 121.7 Million | 120.7 Million | 114.1 Million | 421 Million | 113 Million | 105.4 Million |
| Deferred income taxes | -168.6 Million | -118.1 Million | -190.4 Million | -837.8 Million | -286.3 Million | -125.7 Million |
| Stock-based compensation | 225.1 Million | 223.2 Million | 230.1 Million | 885 Million | 240.4 Million | 203.9 Million |
| Change in working capital | 468 Million | -908.5 Million | 440.5 Million | -94.1 Million | -61.4 Million | -192.3 Million |
| Other non-cash items | -695.6 Million | 540.3 Million | 253 Million | 266.3 Million | -75.6 Million | 115.2 Million |
| Investing Cash Flow | -574.4 Million | -557.2 Million | -1.68 Billion | -3.18 Billion | -66.2 Million | -496.3 Million |
| Investments in PPE | -183.6 Million | -210.9 Million | -161.8 Million | -926.4 Million | -313.5 Million | -176 Million |
| Acquisitions | -20.1 Million | 15.1 Million | - | -54.9 Million | -3.8 Million | 199.9 Million |
| Investment purchases | -4.59 Billion | -4.41 Billion | -5.65 Billion | -11.64 Billion | -2.13 Billion | -3.24 Billion |
| Sales/Maturities of investments | 4.25 Billion | 4.05 Billion | 4.13 Billion | 9.44 Billion | 2.38 Billion | 2.99 Billion |
| Other Investing Activities | -38.2 Million | -371.7 Million | -1.55 Billion | -2.41 Billion | 189 Million | -274.9 Million |
| Financing Cash Flow | -634 Million | -478.1 Million | 47.1 Million | -1.79 Billion | -446.1 Million | -407.3 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -735.1 Million | -603.9 Million | -291.3 Million | -2.93 Billion | -747.1 Million | -675.9 Million |
| Common Stock Issuance | 254.7 Million | 437.6 Million | 682.1 Million | 1.14 Billion | 301 Million | 268.6 Million |
| Other Financing Activities | -153.6 Million | -311.8 Million | -343.7 Million | -700.6 Million | -458.1 Million | -129.4 Million |
| Accounts receivables | -388.9 Million | -494.1 Million | 446.8 Million | -338.8 Million | -82.7 Million | -463.5 Million |
| Accounts payables | 194.4 Million | 204.6 Million | 110.5 Million | 598.6 Million | 25.6 Million | 303.1 Million |
| Inventory | -164.4 Million | -181.8 Million | -155.8 Million | -271.7 Million | -47.3 Million | -77.2 Million |
| Other working capital | 398.2 Million | -437.2 Million | 39 Million | -82.2 Million | 43 Million | 45.3 Million |
| Cash at beginning of period | 1.92 Billion | 2.6 Billion | 2.73 Billion | 3.11 Billion | 2.16 Billion | 1.94 Billion |
| Cash at end of period | 2.01 Billion | 1.92 Billion | 2.6 Billion | 2.73 Billion | 2.73 Billion | 2.16 Billion |
| Capital Expenditure | -183.6 Million | -210.9 Million | -161.8 Million | -926.4 Million | -313.5 Million | -176 Million |
| Effect of forex changes on cash | 800 Thousand | -300 Thousand | -500 Thousand | -400 Thousand | 200 Thousand | -200 Thousand |
| Net cash flow / Change in cash | 83.6 Million | -673.8 Million | -128 Million | -381.6 Million | 577.6 Million | 210.5 Million |
| Free Cash Flow | 1.1 Billion | 143.1 Million | 1.35 Billion | 3.66 Billion | 776.2 Million | 938.3 Million |
VQSSF
JOUT
MCB
KTB-R
FULTP
PEG